Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Augustin

Showing results (301-310 of 443) with videos related to

Pageof 45
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2019
Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientationM Augustin, A Langenbruch, C Blome, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 5, 1998
Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcersM Peschen, C Thimm, A Weyl, et al.
Genes & Development|November 28, 2018
Phosphorylation by the stress-activated MAPK Slt2 down-regulates the yeast TOR complex 2Kristin L Leskoske, Françoise M Roelants, Anita Emmerstorfer-Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2017
Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT studyA Körber, D Thaçi, R von Kiedrowski, et al.
The British Journal of Dermatology|August 4, 2019
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatmentK Reich, M Augustin, D Thaçi, et al.
The British Journal of Dermatology|September 24, 2019
An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12K Papp, C Maari, A Cauthen, et al.
Heart, Lung & Circulation|June 1, 2025
Just Because We Can, Does It Mean We Should? Conservative Management of Penetrating Missile Injury to the HeartKanhua Yin, Garima Thakkar, John M Forman, et al.
Magnetic Resonance in Medicine|October 12, 2000
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosisR Bammer, M Augustin, S Strasser-Fuchs, et al.
The British Journal of Dermatology|May 31, 2017
The global state of psoriasis disease epidemiology: a workshop reportC E M Griffiths, J M van der Walt, D M Ashcroft, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 25, 2021
Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasisR Sommer, M Augustin, C Hilbring, et al.
Pageof 45

Showing results (301-310 of 443) with videos related to

Sort By:
Pageof 45
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2019
Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientationM Augustin, A Langenbruch, C Blome, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|June 5, 1998
Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcersM Peschen, C Thimm, A Weyl, et al.
Genes & Development|November 28, 2018
Phosphorylation by the stress-activated MAPK Slt2 down-regulates the yeast TOR complex 2Kristin L Leskoske, Françoise M Roelants, Anita Emmerstorfer-Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2017
Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT studyA Körber, D Thaçi, R von Kiedrowski, et al.
The British Journal of Dermatology|August 4, 2019
A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatmentK Reich, M Augustin, D Thaçi, et al.
The British Journal of Dermatology|September 24, 2019
An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12K Papp, C Maari, A Cauthen, et al.
Heart, Lung & Circulation|June 1, 2025
Just Because We Can, Does It Mean We Should? Conservative Management of Penetrating Missile Injury to the HeartKanhua Yin, Garima Thakkar, John M Forman, et al.
Magnetic Resonance in Medicine|October 12, 2000
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosisR Bammer, M Augustin, S Strasser-Fuchs, et al.
The British Journal of Dermatology|May 31, 2017
The global state of psoriasis disease epidemiology: a workshop reportC E M Griffiths, J M van der Walt, D M Ashcroft, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 25, 2021
Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasisR Sommer, M Augustin, C Hilbring, et al.
Pageof 45